Differential Mechanisms of Shedding of the Glycosylphosphatidylinositol (GPI)-anchored NKG2D Ligands

Tumor cells release NKG2D ligands to evade NKG2D-mediated immune surveillance. The purpose of our investigation was to explore the cellular mechanisms of release used by various members of the ULBP family. Using biochemical and cellular approaches in both transfectant systems and tumor cell lines, t...

Descripción completa

Detalles Bibliográficos
Autores: Fernández Messina, Lola María, Ashiru, Omodele, Boutet, Philippe, Agüera-González, Sonia, Skepper, Jeremy, Reyburn, Hugh, Valés-Gómez, Mar
Tipo de recurso: artículo
Fecha de publicación:2010
País:España
Institución:Universidad Complutense de Madrid (UCM)
Repositorio:Docta Complutense
Idioma:inglés
OAI Identifier:oai:docta.ucm.es:20.500.14352/97218
Acceso en línea:https://hdl.handle.net/20.500.14352/97218
Access Level:acceso abierto
Palabra clave:616.831-006.484
NKG2D-ligands
Exosomes
NK cells
Metalloproteases
Bioquímica (Biología)
Biología celular (Biología)
Inmunología
Oncología
2412 Inmunología
2403 Bioquímica
2407 Biología Celular
3207 Patología
Descripción
Sumario:Tumor cells release NKG2D ligands to evade NKG2D-mediated immune surveillance. The purpose of our investigation was to explore the cellular mechanisms of release used by various members of the ULBP family. Using biochemical and cellular approaches in both transfectant systems and tumor cell lines, this paper shows that ULBP1, ULBP2, and ULBP3 are released from cells with different kinetics and by distinct mechanisms. Whereas ULBP2 is mainly shed by metalloproteases, ULBP3 is abundantly released as part of membrane vesicles known as exosomes. Interestingly, exosomal ULBP3 protein is much more potent for down-modulation of the NKG2D receptor than soluble ULBP2 protein. This is the first report showing functionally relevant differences in the biochemistry of the three members of the ULBP family and confirms that in depth study of the biochemical features of individual NKG2D ligands will be necessary to understand and manipulate the biology of these proteins for therapy.